Medical Drugs Delivery
Articles & Whitepapers
-
Evaluation of Anti-Stroke Drugs
Stroke, also known as transient ischemic attack or cerebrovascular accident, is an acute brain disease. Usually, a sudden rupture of a blood vessel in the brain or a blockage of a blood vessel that prevents blood from flowing to the brain can cause damage to brain tissue, resulting in a stroke. Long-term strokes can lead to brain damage, disability and even death. The brain serves as a ...
-
Nanoparticle Development: Revolutionizing Drug Delivery Systems
The field of medicine is constantly evolving, with researchers and scientists striving to find innovative ways to deliver drugs effectively and efficiently. One of the most promising technologies ...
News
-
FDA Emerging Technology Program
Broomfield Colorado 6/16/2022. Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug ...
POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as part of Eubiologics’ COVID-19 Vaccine Candidate, EuCorVac-19
CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency
CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies
CD Formulation Incorporates Phase Separation Method for Microsphere Production
Equipment & Solutions
-
Showcase
MSR™ - Microsphere Refiner
The MSR™ MicroSphere Refiner is a cGMP piece of equipment that allows drug developers and manufacturers to complete a wide range of aseptic processes with their microspheres at various scales. It is a one-of-its-kind solution has been developed and refined over decades following a Quality-by-Design (QbD) approach, taking into account the characteristics of microspheres and process ...
Upcoming Events
-
Showcase
12th Microbiome & Probiotics R&D and Business Collaboration Forum
Global Engage is pleased to announce the 12th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum, which is confirmed to be held on April 23-24 2024 in The Netherlands and co-located with the 6th Skin Microbiome & Cosmeceuticals Congress. This world-renowned event which attracted 265 industry, academic, and investment leaders last year, enables the discussion of ...